返回 Agenda
SESSION 11 part 1: STATUS AND CHANGES IN RELATION TO CURRENT DISCLOSURE REQUIREMENTS IN EU AND THE USA
Session Chair(s)
Merete Joergensen, MBA, MSC
Clinical Disclosure and Transparency Expert
Merete-J Consulting, Denmark
Speaker(s)
Update of EU Country Registries/Requirements
Tom Bosch, PHD
Netherlands
Director, Clinical Registry
EU PASS/PAES Requirements for Disclosure
Thomas Goedecke, PHARMD, PHD
European Medicines Agency, Netherlands
Senior Pharmacovigilance Specialist